Endoscopic Submucosal Dissection Market by Product (Grasp, Clips, Gastroscopes, Colonoscopes), Indication (Cancer (Esophageal, Stomach, Colon), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) - Global Forecast to 2027
Endoscopic Submucosal Dissection Market by Product (Grasp, Clips, Gastroscopes, Colonoscopes), Indication (Cancer (Esophageal, Stomach, Colon), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) - Global Forecast to 2027
Abstract
The global endoscopic submucosal dissection market is projected to reach USD 483 million by 2027 from USD 347 million in 2022, at a CAGR of 6.9%.
Endoscopic submucosal dissection (ESD) is an advanced therapeutic endoscopy technique for superficial gastrointestinal neoplasms. In endoscopic submucosal dissection, the equipment includes different types of knives, forceps, snares, and a few other products that support the procedure, as well as accessories used to ease the handling of instruments during surgeries.
The global endoscopic submucosal dissection market is projected to reach USD 483 million by 2027 from USD 347 million in 2022, at a CAGR of 6.9%. Growth in this market is largely driven by the increasing use of endoscopy in detection and treatment procedures, the rising prevalence of cancer, and the growing geriatric population. On the other hand, the dearth of skilled professionals is a key factor restraining the growth of this market.
The gastroscopes and colonoscopes segment accounted for the largest share of the global endoscopic submucosal dissection market
In 2021, the gastroscopes and colonoscopes segment holds the largest share of the global endoscopic submucosal dissection market. The large share of this segment can be attributed to the higher adoption rate of this equipment by end users, the rising preference of patients and doctors for minimally invasive procedures, and ongoing technological advancements in endoscopy procedures.
The stomach cancer segment accounted for the largest share of the endoscopic submucosal dissection market in 2021
Based on indication, the endoscopic submucosal dissection market is segmented into esophageal cancer stomach cancer, colon cancer. The stomach cancer segment holds the largest share of the endoscopic submucosal dissection market in 2021. The large share of this segment can be attributed to the increasing geriatric population in the US, China, Japan, and India and the rising incidence of stomach cancer.
The hospitals' segment is expected to dominate the endoscopic submucosal dissection market during the forecast period
Based on end user, the endoscopic submucosal dissection market is segmented into ambulatory surgical centers, hospitals, specialty clinics, and other end users. The hospitals segment holds the largest share of the endoscopic submucosal dissection market during the forecast period owing to the the increasing per capita income and growing healthcare awareness.
North America dominated the endoscopic submucosal dissection market in 2021
North America dominated the endoscopic submucosal dissection market in 2021. The large share of North America in the global market is attributed to the favorable reimbursement policies for endoscopic procedures in the US, the increasing prevalence of cancer, high investments by hospitals to purchase new equipment and adopt new endoscopic procedures, strong focus on research activities to improve endoscopy techniques, as well as the implementation of a new funding model by Canadian hospitals.
The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs.
The break-up of the primaries is as follows:
•By Company Type– Tier 1- 34%, Tier 2- 38% Tier 3 - 28%
•By Designation— C level - 26%, Managers & Other Level - 74%
•By Region— North America - 17%, Europe - 39%, Asia Pacific - 28%
Key players in the endoscopic submucosal dissection market
The prominent players in the endoscopic submucosal dissection market are Olympus Corporation (Japan), Boston Scientific Corporation (US), Sumitomo Bakelite Co., Ltd. (Japan), Creo Medical Group PLC (UK), Medtronic (Ireland), HOYA Corporation (Japan), ConMed Corporation (US), Steris Plc (Ireland), FUJIFILM Holdings Corporation (Japan), MTW Endoskopie Manufaktur (Germany), Ovesco Endoscopy AG (Germany), Zeon Medical Inc. (Japan), Micro-Tech Endoscopy (China), Karl Storz SE & CO. KG (Germany), Cook Medical (US), Leo Medical Co., Ltd. (China), Erbe Elektromedizin GmbH (Germany), Taewoong Medical Co., Ltd. (South Korea), DCC Healthcare Limited (Ireland), Kossen Co., Ltd. (South Korea), INNOVAMEDICA S.p.A. (Italy), Jiangsu Vedkang Medical Science and Technology Co., Ltd. (China), Hangzhou AGS Medical Technological Co., Ltd. (China), and Beijing ZKSK Technology Co., Ltd. (China).
Research Coverage:
The report analyzes the endoscopic submucosal dissection market and aims at estimating the market size and future growth potential of this market based on various segments such asproduct, indication, end user and region. The report also includes a product portfolio matrix of various endoscopic submucosal dissection products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
•Market Penetration: Comprehensive information on product portfolios offered by the top players in the global endoscopic submucosal dissection market. The report analyzes this market by product, indication, end user and region.
•Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global endoscopic submucosal dissection market.
•Market Development: Comprehensive information on the lucrative emerging markets byproduct, indication, end user and region.
•Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global endoscopic submucosal dissection market.
•Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global endoscopic submucosal dissection market.
Content
Table of Contents
1INTRODUCTION26
1.1STUDY OBJECTIVES26
1.2MARKET DEFINITION27
1.2.1INCLUSIONS AND EXCLUSIONS27
1.3MARKET SCOPE28
1.3.1MARKETS COVERED28
FIGURE 1ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SEGMENTATION28
1.4YEARS CONSIDERED29
1.5CURRENCY CONSIDERED29
TABLE 1STANDARD CURRENCY CONVERSION RATES29
1.6SCOPE-RELATED LIMITATIONS30
1.7STAKEHOLDERS30
2RESEARCH METHODOLOGY31
2.1RESEARCH DATA31
FIGURE 2RESEARCH DESIGN31
2.1.1SECONDARY DATA31
2.1.1.1Key data from secondary sources33
2.1.2PRIMARY DATA33
FIGURE 3PRIMARY SOURCES33
2.1.2.1Key data from primary sources34
2.1.2.2Key industry insights35
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS35
FIGURE 5BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION36
FIGURE 6BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION36
2.2MARKET SIZE ESTIMATION37
FIGURE 7SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS37
FIGURE 8REVENUE SHARE ANALYSIS ILLUSTRATION: OLYMPUS CORPORATION38
FIGURE 9SUPPLY-SIDE MARKET SIZE ESTIMATION: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET (2021)39
FIGURE 10CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027)40
FIGURE 11CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS41
FIGURE 12TOP-DOWN APPROACH41
2.3MARKET BREAKDOWN AND DATA TRIANGULATION42
FIGURE 13DATA TRIANGULATION METHODOLOGY43
2.4MARKET SHARE ESTIMATION43
2.5STUDY ASSUMPTIONS44
2.6METHODOLOGY-RELATED LIMITATIONS44
2.7RISK ASSESSMENT44
TABLE 2RISK ASSESSMENT: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET44
3EXECUTIVE SUMMARY45
FIGURE 14ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)45
FIGURE 15ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2022 VS. 2027 (USD MILLION)46
FIGURE 16ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)46
FIGURE 17GEOGRAPHIC SNAPSHOT OF ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET47
4PREMIUM INSIGHTS48
4.1ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET OVERVIEW48
FIGURE 18INCREASING USE OF ENDOSCOPY IN DETECTION AND TREATMENT PROCEDURES TO DRIVE MARKET GROWTH48
4.2ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT AND COUNTRY49
FIGURE 19GASTROSCOPES AND COLONOSCOPES HELD LARGEST SHARE OF ASIA PACIFIC MARKET IN 202149
4.3ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: GEOGRAPHIC MIX50
FIGURE 20MARKET IN ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD50
4.4ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: REGIONAL MIX51
FIGURE 21NORTH AMERICA TO BE LARGEST MARKET FOR ENDOSCOPIC SUBMUCOSAL DISSECTION PRODUCTS THROUGHOUT FORECAST PERIOD51
4.5ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DEVELOPED VS. DEVELOPING MARKETS51
FIGURE 22DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD51
5MARKET OVERVIEW52
5.1INTRODUCTION52
5.2MARKET DYNAMICS52
FIGURE 23ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES52
5.2.1DRIVERS53
5.2.1.1Increasing use of endoscopy in detection and treatment procedures53
5.2.1.2Rising prevalence of cancer53
FIGURE 24GLOBAL CANCER INCIDENCE, 2008–203054
5.2.1.3Growing geriatric population54
FIGURE 25SHARE OF GERIATRIC POPULATION, BY REGION (2010–2030)55
TABLE 3GLOBAL CANCER INCIDENCE FOR GERIATRIC POPULATION (65–85+), 2020 VS. 204055
5.2.2RESTRAINTS55
5.2.2.1Dearth of skilled professionals55
5.2.2.2High overhead cost of ESD procedures with limited reimbursements56
5.2.3OPPORTUNITIES56
5.2.3.1Growing demand for minimally invasive procedures56
5.2.3.2Growing investments in research and development of endoscopy technology56
TABLE 4MAJOR DEVELOPMENTS57
5.2.3.3Expected increase in adoption of and preference for endoscopic submucosal dissection procedures in developing countries57
5.2.4CHALLENGES58
5.2.4.1Higher rate of complications58
5.2.4.2Risk of post-operative infection58
5.3INDUSTRY TRENDS59
5.3.1ADVANCES IN TRACTION METHODS FOR ENDOSCOPIC SUBMUCOSAL DISSECTION59
5.3.2ROBOT-ASSISTED ENDOSCOPIC SUBMUCOSAL DISSECTION60
5.4REGULATORY ANALYSIS61
5.4.1REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS61
TABLE 5NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS61
TABLE 6EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS62
TABLE 7REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS62
5.4.2NORTH AMERICA63
5.4.2.1US63
5.4.2.2Canada63
5.4.3EUROPE63
5.4.3.1Germany64
5.4.3.2France64
5.4.3.3UK64
5.4.3.4Italy65
5.5ECOSYSTEM MARKET MAP65
FIGURE 26ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: ECOSYSTEM MARKET MAP66
5.6VALUE CHAIN ANALYSIS66
FIGURE 27ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: VALUE CHAIN ANALYSIS67
5.7PORTER’S FIVE FORCES ANALYSIS67
TABLE 8ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: PORTER’S FIVE FORCES ANALYSIS67
5.7.1THREAT OF NEW ENTRANTS68
5.7.1.1High capital requirement68
5.7.1.2High preference for products from well-established brands68
5.7.2THREAT OF SUBSTITUTES68
5.7.2.1Presence of substitute therapies for endoscopic submucosal dissection68
5.7.3BARGAINING POWER OF SUPPLIERS68
5.7.3.1Presence of several raw material suppliers69
5.7.3.2Supplier switching cost69
5.7.4BARGAINING POWER OF BUYERS69
5.7.4.1Limited number of companies offering premium products at global level69
5.7.5INTENSITY OF COMPETITIVE RIVALRY69
5.7.5.1Increasing demand for high-quality and innovative products69
5.7.5.2Lucrative growth potential in emerging markets69
5.8INDICATIVE PRICING MODEL ANALYSIS69
TABLE 9AVERAGE SELLING PRICE, BY PRODUCT (USD)70
5.9PATENT ANALYSIS70
5.9.1PATENT PUBLICATION TRENDS FOR ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET70
FIGURE 28GLOBAL PATENT PUBLICATION TRENDS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, 2015–202271
5.9.2TOP APPLICANTS (COMPANIES) FOR PATENTS RELATED TO ENDOSCOPIC SUBMUCOSAL DISSECTION DEVICES AND MATERIALS71
FIGURE 29TOP COMPANIES THAT APPLIED FOR PATENTS RELATED TO ENDOSCOPIC SUBMUCOSAL DISSECTION DEVICES AND MATERIALS, 2015–202271
5.9.3JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET72
FIGURE 30JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR PATENTS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, 2015–202272
5.10SUPPLY CHAIN ANALYSIS72
FIGURE 31ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: STAKEHOLDERS IN SUPPLY CHAIN73
5.11KEY CONFERENCES AND EVENTS DURING 2022–202374
TABLE 10ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DETAILED LIST OF CONFERENCES AND EVENTS74
5.12KEY STAKEHOLDERS AND BUYING CRITERIA75
5.12.1KEY STAKEHOLDERS IN BUYING PROCESS75
FIGURE 32INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS75
TABLE 11INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS75
5.12.2BUYING CRITERIA75
FIGURE 33KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS75
TABLE 12KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS76
6ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT77
6.1INTRODUCTION78
TABLE 13ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)78
6.2GASTROSCOPES AND COLONOSCOPES78
6.2.1RISE IN COLON CANCER INCIDENCE TO DRIVE GROWTH78
TABLE 14ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR GASTROSCOPES AND COLONOSCOPES, BY COUNTRY, 2020–2027 (USD MILLION)79
6.3KNIVES80
6.3.1IMPROVED EFFICACY, SAFETY, AND COST-EFFECTIVENESS OF KNIVES TO DRIVE MARKET GROWTH80
TABLE 15ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR KNIVES, BY COUNTRY, 2020–2027 (USD MILLION)80
6.4INJECTION AGENTS81
6.4.1NEED FOR LOW-COST INJECTION AGENTS TO BOOST GROWTH81
TABLE 16ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR INJECTION AGENTS, BY COUNTRY, 2020–2027 (USD MILLION)81
6.5TISSUE RETRACTORS82
6.5.1RISING NUMBER OF SURGICAL PROCEDURES TO AID ADOPTION OF TISSUE RETRACTORS82
TABLE 17ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR TISSUE RETRACTORS, BY COUNTRY, 2020–2027 (USD MILLION)82
6.6GRASPERS/CLIPS83
6.6.1PATIENT SAFETY AND HIGH PRECISION OFFERED BY GRASPERS TO DRIVE THEIR DEMAND83
TABLE 18ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR GRASPERS/CLIPS, BY COUNTRY, 2020–2027 (USD MILLION)83
6.7OTHER PRODUCTS84
TABLE 19ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)84
7ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION85
7.1INTRODUCTION86
TABLE 20ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)86
TABLE 21ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2021 (NUMBER OF PROCEDURES)86
7.2STOMACH CANCER87
7.2.1STOMACH CANCER OR GASTRIC CANCER ASSOCIATED WITH SIGNIFICANT PROPORTION OF ALL CANCER DEATHS87
TABLE 22ESTIMATED NUMBER OF NEW CASES OF STOMACH CANCER, BY REGION (2020–2040)87
TABLE 23ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR STOMACH CANCER, BY COUNTRY, 2020–2027 (USD MILLION)88
TABLE 24ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR STOMACH CANCER, BY REGION, 2021 (NUMBER OF PROCEDURES)88
7.3COLON CANCER89
7.3.1COLON CANCER IS THIRD-MOST-COMMON CANCER AND SECOND-LEADING CAUSE OF CANCER DEATHS WORLDWIDE89
TABLE 25ESTIMATED NUMBER OF NEW CASES OF COLON CANCER, BY REGION (2020–2040)89
TABLE 26ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR COLON CANCER, BY COUNTRY, 2020–2027 (USD MILLION)90
TABLE 27ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR COLON CANCER, BY REGION, 2021 (NUMBER OF PROCEDURES)90
7.4ESOPHAGEAL CANCER91
7.4.1GROWING PREVALENCE OF ESOPHAGEAL CANCER ATTRIBUTED TO EXCESS TOBACCO AND ALCOHOL USE91
TABLE 28ESTIMATED NUMBER OF NEW CASES OF ESOPHAGEAL CANCER, BY REGION (2020–2040)91
TABLE 29ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR ESOPHAGEAL CANCER, BY COUNTRY, 2020–2027 (USD MILLION)92
TABLE 30ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR ESOPHAGEAL CANCER, BY REGION, 2021 (NUMBER OF PROCEDURES)92
8ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER93
8.1INTRODUCTION94
TABLE 31ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)94
8.2HOSPITALS94
8.2.1GROWING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES AND ESD PROCEDURES TO SUPPORT GROWTH94
TABLE 32ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)95
8.3SPECIALTY CLINICS95
8.3.1TRANSITION FROM HOSPITAL-BASED PROCEDURES TO CLINIC-BASED PROCEDURES TO BOOST GROWTH95
TABLE 33ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)96
8.4AMBULATORY SURGICAL CENTERS97
8.4.1GROWTH IN ASC SEGMENT DRIVEN BY INCREASING NUMBER OF OUTPATIENT VISITS97
TABLE 34ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)98
8.5OTHER END USERS98
TABLE 35ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)99
9ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION100
9.1INTRODUCTION101
FIGURE 34ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES101
TABLE 36ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION, 2020–2027 (USD MILLION)102
9.2NORTH AMERICA102
FIGURE 35NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SNAPSHOT103
TABLE 37NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)103
TABLE 38NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)104
TABLE 39NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)104
TABLE 40NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)104
9.2.1US105
9.2.1.1US is largest market for endoscopic submucosal dissection products105
TABLE 41US: MACROECONOMIC INDICATORS106
TABLE 42US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)106
TABLE 43US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)106
TABLE 44US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)107
9.2.2CANADA107
9.2.2.1Slower healthcare development in Canada over past decade to restrain growth107
TABLE 45AGE-STANDARDIZED INCIDENCE RATES (ASIR) FOR SELECTED CANCERS IN MEN AND WOMEN IN CANADA, 2020 VS. 2040108
TABLE 46CANADA: MACROECONOMIC INDICATORS109
TABLE 47CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)109
TABLE 48CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)109
TABLE 49CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)110
9.3EUROPE110
TABLE 50EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)110
TABLE 51EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)111
TABLE 52EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)111
TABLE 53EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)111
9.3.1GERMANY112
9.3.1.1Germany to account for largest share of European market112
TABLE 54GERMANY: MACROECONOMIC INDICATORS112
TABLE 55GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)113
TABLE 56GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)113
TABLE 57GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)113
9.3.2FRANCE114
9.3.2.1High-quality healthcare system offering coverage to all citizens to support market growth114
TABLE 58FRANCE: MACROECONOMIC INDICATORS114
TABLE 59FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)115
TABLE 60FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)115
TABLE 61FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)115
9.3.3UK116
9.3.3.1Investments by hospitals to purchase new and advanced endoscopic submucosal dissection equipment to propel market116
TABLE 62UK: MACROECONOMIC INDICATORS116
TABLE 63UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)117
TABLE 64UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)117
TABLE 65UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)117
9.3.4ITALY118
9.3.4.1Receptivity of government toward high-quality and technologically advanced equipment to foster growth118
TABLE 66ITALY: MACROECONOMIC INDICATORS118
TABLE 67ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)119
TABLE 68ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)119
TABLE 69ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)119
9.3.5SPAIN120
9.3.5.1Rising prevalence of cancer to drive market growth120
TABLE 70SPAIN: MACROECONOMIC INDICATORS120
TABLE 71SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)120
TABLE 72SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)121
TABLE 73SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)121
9.3.6REST OF EUROPE121
TABLE 74ROE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)122
TABLE 75ROE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)122
TABLE 76ROE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)123
9.4ASIA PACIFIC123
FIGURE 36ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SNAPSHOT124
TABLE 77ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)125
TABLE 78ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)125
TABLE 79ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)125
TABLE 80ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)126
9.4.1JAPAN126
9.4.1.1Supportive medical device reimbursement policies to drive market growth126
TABLE 81JAPAN: MACROECONOMIC INDICATORS127
TABLE 82JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)127
TABLE 83JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)127
TABLE 84JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)128
9.4.2CHINA128
9.4.2.1Large patient population and strong need for healthcare infrastructure improvements to boost market growth128
TABLE 85CHINA: MACROECONOMIC INDICATORS129
TABLE 86CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)129
TABLE 87CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)129
TABLE 88CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)130
9.4.3INDIA130
9.4.3.1Favorable government initiatives for healthcare infrastructure improvements to support market growth130
TABLE 89INDIA: MACROECONOMIC INDICATORS131
TABLE 90INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)131
TABLE 91INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)131
TABLE 92INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)132
9.4.4REST OF ASIA PACIFIC132
TABLE 93ROAPAC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)133
TABLE 94ROAPAC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)133
TABLE 95ROAPAC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)133
9.5LATIN AMERICA134
9.5.1INCREASING PURCHASING POWER AND HEALTHCARE AFFORDABILITY WILL FAVOR MARKET GROWTH134
TABLE 96LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)135
TABLE 97LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)135
TABLE 98LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)135
9.6MIDDLE EAST AND AFRICA136
9.6.1HEALTHCARE INFRASTRUCTURAL ADVANCEMENTS WILL CREATE NEED FOR HOSPITAL EQUIPMENT AND MEDICAL DEVICES136
TABLE 99MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)136
TABLE 100MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)137
TABLE 101MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)137
10COMPETITIVE LANDSCAPE138
10.1INTRODUCTION138
10.2STRATEGIES ADOPTED BY KEY PLAYERS138
10.3REVENUE ANALYSIS OF KEY MARKET PLAYERS139
FIGURE 37REVENUE ANALYSIS OF KEY PLAYERS OPERATING IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET139
10.4MARKET SHARE ANALYSIS139
FIGURE 38ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SHARE, BY KEY PLAYER (2021)140
10.5COMPANY FOOTPRINT ANALYSIS140
10.5.1FOOTPRINT OF COMPANIES, BY PRODUCT141
10.5.2FOOTPRINT OF COMPANIES, BY END USER142
10.5.3FOOTPRINT OF COMPANIES, BY REGION143
10.6COMPANY EVALUATION MATRIX144
10.6.1STARS144
10.6.2EMERGING LEADERS144
10.6.3PERVASIVE PLAYERS144
10.6.4PARTICIPANTS144
FIGURE 39ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: COMPANY EVALUATION MATRIX145
10.7COMPETITIVE BENCHMARKING146
TABLE 102ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: KEY START-UPS/SMES146
10.8COMPETITIVE SCENARIO146
10.8.1PRODUCT LAUNCHES147
TABLE 103ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: PRODUCT LAUNCHES (JANUARY 2019–DECEMBER 2022)147
10.8.2DEALS148
TABLE 104ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DEALS (JANUARY 2019–DECEMBER 2022)148
10.8.3OTHER DEVELOPMENTS149
TABLE 105ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: OTHER DEVELOPMENTS (JANUARY 2019–DECEMBER 2022)149
11COMPANY PROFILES150
(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)*
11.1KEY PLAYERS150
11.1.1OLYMPUS CORPORATION150
TABLE 106OLYMPUS CORPORATION: BUSINESS OVERVIEW150
FIGURE 40COMPANY SNAPSHOT: OLYMPUS CORPORATION (2022)151
11.1.2FUJIFILM HOLDINGS CORPORATION154
TABLE 107FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW154
FIGURE 41COMPANY SNAPSHOT: FUJIFILM HOLDINGS CORPORATION (2021)155
11.1.3BOSTON SCIENTIFIC CORPORATION158
TABLE 108BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW158
FIGURE 42COMPANY SNAPSHOT: BOSTON SCIENTIFIC CORPORATION (2021)159
11.1.4MEDTRONIC161
TABLE 109MEDTRONIC: BUSINESS OVERVIEW161
FIGURE 43COMPANY SNAPSHOT: MEDTRONIC (2022)162
11.1.5SUMITOMO BAKELITE CO., LTD.164
TABLE 110SUMITOMO BAKELITE CO., LTD.: BUSINESS OVERVIEW164
FIGURE 44COMPANY SNAPSHOT: SUMITOMO BAKELITE CO., LTD. (2021)165
11.1.6CREO MEDICAL GROUP PLC167
TABLE 111CREO MEDICAL GROUP PLC: BUSINESS OVERVIEW167
FIGURE 45COMPANY SNAPSHOT: CREO MEDICAL GROUP PLC (2021)167
11.1.7HOYA CORPORATION170
TABLE 112HOYA CORPORATION: BUSINESS OVERVIEW170
FIGURE 46COMPANY SNAPSHOT: HOYA CORPORATION (2022)171
11.1.8CONMED CORPORATION172
TABLE 113CONMED CORPORATION: BUSINESS OVERVIEW172
FIGURE 47COMPANY SNAPSHOT: CONMED CORPORATION (2021)173
11.1.9STERIS PLC174
TABLE 114STERIS PLC: BUSINESS OVERVIEW174
FIGURE 48COMPANY SNAPSHOT: STERIS PLC (2022)175
11.1.10MTW ENDOSKOPIE MANUFAKTUR177
TABLE 115MTW ENDOSKOPIE MANUFAKTUR: BUSINESS OVERVIEW177
11.2OTHER PLAYERS178
11.2.1OVESCO ENDOSCOPY AG178
TABLE 116OVESCO ENDOSCOPY AG: BUSINESS OVERVIEW178
11.2.2ZEON MEDICAL INC.179
TABLE 117ZEON MEDICAL INC.: BUSINESS OVERVIEW179
11.2.3MICRO-TECH ENDOSCOPY180
TABLE 118MICRO-TECH ENDOSCOPY: BUSINESS OVERVIEW180
11.2.4KARL STORZ SE & CO. KG182
TABLE 119KARL STORZ SE & CO. KG.: BUSINESS OVERVIEW182
11.2.5COOK MEDICAL183
TABLE 120COOK MEDICAL: BUSINESS OVERVIEW183
11.2.6LEO MEDICAL CO., LTD.185
TABLE 121LEO MEDICAL CO., LTD.: BUSINESS OVERVIEW185
11.2.7ERBE ELEKTROMEDIZIN GMBH186
TABLE 122ERBE ELEKTROMEDIZIN GMBH: BUSINESS OVERVIEW186
11.2.8TAEWOONG MEDICAL CO., LTD.187
TABLE 123TAEWOONG MEDICAL CO., LTD.: BUSINESS OVERVIEW187
11.2.9DCC HEALTHCARE LIMITED188
TABLE 124DCC HEALTHCARE LIMITED: BUSINESS OVERVIEW188
11.2.10KOSSEN CO., LTD.189
TABLE 125KOSSEN CO., LTD.: BUSINESS OVERVIEW189
11.2.11INNOVAMEDICA S.P.A.190
TABLE 126INNOVAMEDICA S.P.A.: BUSINESS OVERVIEW190
11.2.12JIANGSU VEDKANG MEDICAL SCIENCE AND TECHNOLOGY CO., LTD.191
TABLE 127JIANGSU VEDKANG MEDICAL SCIENCE AND TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW191
11.2.13HANGZHOU AGS MEDICAL TECHNOLOGICAL CO., LTD.192
TABLE 128HANGZHOU AGS MEDICAL TECHNOLOGICAL CO., LTD.: BUSINESS OVERVIEW192
11.2.14BEIJING ZKSK TECHNOLOGY CO., LTD.193
TABLE 129BEIJING ZKSK TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW193
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies.
12APPENDIX194
12.1DISCUSSION GUIDE194
12.2KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL199
12.3CUSTOMIZATION OPTIONS201
12.4RELATED REPORTS201
12.5AUTHOR DETAILS202
Endoscopic submucosal dissection (ESD) is an advanced therapeutic endoscopy technique for superficial gastrointestinal neoplasms. In endoscopic submucosal dissection, the equipment includes different types of knives, forceps, snares, and a few other products that support the procedure, as well as accessories used to ease the handling of instruments during surgeries.
The global endoscopic submucosal dissection market is projected to reach USD 483 million by 2027 from USD 347 million in 2022, at a CAGR of 6.9%. Growth in this market is largely driven by the increasing use of endoscopy in detection and treatment procedures, the rising prevalence of cancer, and the growing geriatric population. On the other hand, the dearth of skilled professionals is a key factor restraining the growth of this market.
The gastroscopes and colonoscopes segment accounted for the largest share of the global endoscopic submucosal dissection market
In 2021, the gastroscopes and colonoscopes segment holds the largest share of the global endoscopic submucosal dissection market. The large share of this segment can be attributed to the higher adoption rate of this equipment by end users, the rising preference of patients and doctors for minimally invasive procedures, and ongoing technological advancements in endoscopy procedures.
The stomach cancer segment accounted for the largest share of the endoscopic submucosal dissection market in 2021
Based on indication, the endoscopic submucosal dissection market is segmented into esophageal cancer stomach cancer, colon cancer. The stomach cancer segment holds the largest share of the endoscopic submucosal dissection market in 2021. The large share of this segment can be attributed to the increasing geriatric population in the US, China, Japan, and India and the rising incidence of stomach cancer.
The hospitals' segment is expected to dominate the endoscopic submucosal dissection market during the forecast period
Based on end user, the endoscopic submucosal dissection market is segmented into ambulatory surgical centers, hospitals, specialty clinics, and other end users. The hospitals segment holds the largest share of the endoscopic submucosal dissection market during the forecast period owing to the the increasing per capita income and growing healthcare awareness.
North America dominated the endoscopic submucosal dissection market in 2021
North America dominated the endoscopic submucosal dissection market in 2021. The large share of North America in the global market is attributed to the favorable reimbursement policies for endoscopic procedures in the US, the increasing prevalence of cancer, high investments by hospitals to purchase new equipment and adopt new endoscopic procedures, strong focus on research activities to improve endoscopy techniques, as well as the implementation of a new funding model by Canadian hospitals.
The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs.
The break-up of the primaries is as follows:
•By Company Type– Tier 1- 34%, Tier 2- 38% Tier 3 - 28%
•By Designation— C level - 26%, Managers & Other Level - 74%
•By Region— North America - 17%, Europe - 39%, Asia Pacific - 28%
Key players in the endoscopic submucosal dissection market
The prominent players in the endoscopic submucosal dissection market are Olympus Corporation (Japan), Boston Scientific Corporation (US), Sumitomo Bakelite Co., Ltd. (Japan), Creo Medical Group PLC (UK), Medtronic (Ireland), HOYA Corporation (Japan), ConMed Corporation (US), Steris Plc (Ireland), FUJIFILM Holdings Corporation (Japan), MTW Endoskopie Manufaktur (Germany), Ovesco Endoscopy AG (Germany), Zeon Medical Inc. (Japan), Micro-Tech Endoscopy (China), Karl Storz SE & CO. KG (Germany), Cook Medical (US), Leo Medical Co., Ltd. (China), Erbe Elektromedizin GmbH (Germany), Taewoong Medical Co., Ltd. (South Korea), DCC Healthcare Limited (Ireland), Kossen Co., Ltd. (South Korea), INNOVAMEDICA S.p.A. (Italy), Jiangsu Vedkang Medical Science and Technology Co., Ltd. (China), Hangzhou AGS Medical Technological Co., Ltd. (China), and Beijing ZKSK Technology Co., Ltd. (China).
Research Coverage:
The report analyzes the endoscopic submucosal dissection market and aims at estimating the market size and future growth potential of this market based on various segments such asproduct, indication, end user and region. The report also includes a product portfolio matrix of various endoscopic submucosal dissection products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
•Market Penetration: Comprehensive information on product portfolios offered by the top players in the global endoscopic submucosal dissection market. The report analyzes this market by product, indication, end user and region.
•Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global endoscopic submucosal dissection market.
•Market Development: Comprehensive information on the lucrative emerging markets byproduct, indication, end user and region.
•Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global endoscopic submucosal dissection market.
•Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global endoscopic submucosal dissection market.
1INTRODUCTION26
1.1STUDY OBJECTIVES26
1.2MARKET DEFINITION27
1.2.1INCLUSIONS AND EXCLUSIONS27
1.3MARKET SCOPE28
1.3.1MARKETS COVERED28
FIGURE 1ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SEGMENTATION28
1.4YEARS CONSIDERED29
1.5CURRENCY CONSIDERED29
TABLE 1STANDARD CURRENCY CONVERSION RATES29
1.6SCOPE-RELATED LIMITATIONS30
1.7STAKEHOLDERS30
2RESEARCH METHODOLOGY31
2.1RESEARCH DATA31
FIGURE 2RESEARCH DESIGN31
2.1.1SECONDARY DATA31
2.1.1.1Key data from secondary sources33
2.1.2PRIMARY DATA33
FIGURE 3PRIMARY SOURCES33
2.1.2.1Key data from primary sources34
2.1.2.2Key industry insights35
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS35
FIGURE 5BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION36
FIGURE 6BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION36
2.2MARKET SIZE ESTIMATION37
FIGURE 7SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS37
FIGURE 8REVENUE SHARE ANALYSIS ILLUSTRATION: OLYMPUS CORPORATION38
FIGURE 9SUPPLY-SIDE MARKET SIZE ESTIMATION: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET (2021)39
FIGURE 10CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027)40
FIGURE 11CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS41
FIGURE 12TOP-DOWN APPROACH41
2.3MARKET BREAKDOWN AND DATA TRIANGULATION42
FIGURE 13DATA TRIANGULATION METHODOLOGY43
2.4MARKET SHARE ESTIMATION43
2.5STUDY ASSUMPTIONS44
2.6METHODOLOGY-RELATED LIMITATIONS44
2.7RISK ASSESSMENT44
TABLE 2RISK ASSESSMENT: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET44
3EXECUTIVE SUMMARY45
FIGURE 14ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)45
FIGURE 15ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2022 VS. 2027 (USD MILLION)46
FIGURE 16ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)46
FIGURE 17GEOGRAPHIC SNAPSHOT OF ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET47
4PREMIUM INSIGHTS48
4.1ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET OVERVIEW48
FIGURE 18INCREASING USE OF ENDOSCOPY IN DETECTION AND TREATMENT PROCEDURES TO DRIVE MARKET GROWTH48
4.2ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT AND COUNTRY49
FIGURE 19GASTROSCOPES AND COLONOSCOPES HELD LARGEST SHARE OF ASIA PACIFIC MARKET IN 202149
4.3ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: GEOGRAPHIC MIX50
FIGURE 20MARKET IN ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD50
4.4ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: REGIONAL MIX51
FIGURE 21NORTH AMERICA TO BE LARGEST MARKET FOR ENDOSCOPIC SUBMUCOSAL DISSECTION PRODUCTS THROUGHOUT FORECAST PERIOD51
4.5ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DEVELOPED VS. DEVELOPING MARKETS51
FIGURE 22DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD51
5MARKET OVERVIEW52
5.1INTRODUCTION52
5.2MARKET DYNAMICS52
FIGURE 23ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES52
5.2.1DRIVERS53
5.2.1.1Increasing use of endoscopy in detection and treatment procedures53
5.2.1.2Rising prevalence of cancer53
FIGURE 24GLOBAL CANCER INCIDENCE, 2008–203054
5.2.1.3Growing geriatric population54
FIGURE 25SHARE OF GERIATRIC POPULATION, BY REGION (2010–2030)55
TABLE 3GLOBAL CANCER INCIDENCE FOR GERIATRIC POPULATION (65–85+), 2020 VS. 204055
5.2.2RESTRAINTS55
5.2.2.1Dearth of skilled professionals55
5.2.2.2High overhead cost of ESD procedures with limited reimbursements56
5.2.3OPPORTUNITIES56
5.2.3.1Growing demand for minimally invasive procedures56
5.2.3.2Growing investments in research and development of endoscopy technology56
TABLE 4MAJOR DEVELOPMENTS57
5.2.3.3Expected increase in adoption of and preference for endoscopic submucosal dissection procedures in developing countries57
5.2.4CHALLENGES58
5.2.4.1Higher rate of complications58
5.2.4.2Risk of post-operative infection58
5.3INDUSTRY TRENDS59
5.3.1ADVANCES IN TRACTION METHODS FOR ENDOSCOPIC SUBMUCOSAL DISSECTION59
5.3.2ROBOT-ASSISTED ENDOSCOPIC SUBMUCOSAL DISSECTION60
5.4REGULATORY ANALYSIS61
5.4.1REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS61
TABLE 5NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS61
TABLE 6EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS62
TABLE 7REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS62
5.4.2NORTH AMERICA63
5.4.2.1US63
5.4.2.2Canada63
5.4.3EUROPE63
5.4.3.1Germany64
5.4.3.2France64
5.4.3.3UK64
5.4.3.4Italy65
5.5ECOSYSTEM MARKET MAP65
FIGURE 26ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: ECOSYSTEM MARKET MAP66
5.6VALUE CHAIN ANALYSIS66
FIGURE 27ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: VALUE CHAIN ANALYSIS67
5.7PORTER’S FIVE FORCES ANALYSIS67
TABLE 8ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: PORTER’S FIVE FORCES ANALYSIS67
5.7.1THREAT OF NEW ENTRANTS68
5.7.1.1High capital requirement68
5.7.1.2High preference for products from well-established brands68
5.7.2THREAT OF SUBSTITUTES68
5.7.2.1Presence of substitute therapies for endoscopic submucosal dissection68
5.7.3BARGAINING POWER OF SUPPLIERS68
5.7.3.1Presence of several raw material suppliers69
5.7.3.2Supplier switching cost69
5.7.4BARGAINING POWER OF BUYERS69
5.7.4.1Limited number of companies offering premium products at global level69
5.7.5INTENSITY OF COMPETITIVE RIVALRY69
5.7.5.1Increasing demand for high-quality and innovative products69
5.7.5.2Lucrative growth potential in emerging markets69
5.8INDICATIVE PRICING MODEL ANALYSIS69
TABLE 9AVERAGE SELLING PRICE, BY PRODUCT (USD)70
5.9PATENT ANALYSIS70
5.9.1PATENT PUBLICATION TRENDS FOR ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET70
FIGURE 28GLOBAL PATENT PUBLICATION TRENDS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, 2015–202271
5.9.2TOP APPLICANTS (COMPANIES) FOR PATENTS RELATED TO ENDOSCOPIC SUBMUCOSAL DISSECTION DEVICES AND MATERIALS71
FIGURE 29TOP COMPANIES THAT APPLIED FOR PATENTS RELATED TO ENDOSCOPIC SUBMUCOSAL DISSECTION DEVICES AND MATERIALS, 2015–202271
5.9.3JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET72
FIGURE 30JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR PATENTS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, 2015–202272
5.10SUPPLY CHAIN ANALYSIS72
FIGURE 31ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: STAKEHOLDERS IN SUPPLY CHAIN73
5.11KEY CONFERENCES AND EVENTS DURING 2022–202374
TABLE 10ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DETAILED LIST OF CONFERENCES AND EVENTS74
5.12KEY STAKEHOLDERS AND BUYING CRITERIA75
5.12.1KEY STAKEHOLDERS IN BUYING PROCESS75
FIGURE 32INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS75
TABLE 11INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS75
5.12.2BUYING CRITERIA75
FIGURE 33KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS75
TABLE 12KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS76
6ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT77
6.1INTRODUCTION78
TABLE 13ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)78
6.2GASTROSCOPES AND COLONOSCOPES78
6.2.1RISE IN COLON CANCER INCIDENCE TO DRIVE GROWTH78
TABLE 14ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR GASTROSCOPES AND COLONOSCOPES, BY COUNTRY, 2020–2027 (USD MILLION)79
6.3KNIVES80
6.3.1IMPROVED EFFICACY, SAFETY, AND COST-EFFECTIVENESS OF KNIVES TO DRIVE MARKET GROWTH80
TABLE 15ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR KNIVES, BY COUNTRY, 2020–2027 (USD MILLION)80
6.4INJECTION AGENTS81
6.4.1NEED FOR LOW-COST INJECTION AGENTS TO BOOST GROWTH81
TABLE 16ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR INJECTION AGENTS, BY COUNTRY, 2020–2027 (USD MILLION)81
6.5TISSUE RETRACTORS82
6.5.1RISING NUMBER OF SURGICAL PROCEDURES TO AID ADOPTION OF TISSUE RETRACTORS82
TABLE 17ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR TISSUE RETRACTORS, BY COUNTRY, 2020–2027 (USD MILLION)82
6.6GRASPERS/CLIPS83
6.6.1PATIENT SAFETY AND HIGH PRECISION OFFERED BY GRASPERS TO DRIVE THEIR DEMAND83
TABLE 18ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR GRASPERS/CLIPS, BY COUNTRY, 2020–2027 (USD MILLION)83
6.7OTHER PRODUCTS84
TABLE 19ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)84
7ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION85
7.1INTRODUCTION86
TABLE 20ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)86
TABLE 21ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2021 (NUMBER OF PROCEDURES)86
7.2STOMACH CANCER87
7.2.1STOMACH CANCER OR GASTRIC CANCER ASSOCIATED WITH SIGNIFICANT PROPORTION OF ALL CANCER DEATHS87
TABLE 22ESTIMATED NUMBER OF NEW CASES OF STOMACH CANCER, BY REGION (2020–2040)87
TABLE 23ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR STOMACH CANCER, BY COUNTRY, 2020–2027 (USD MILLION)88
TABLE 24ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR STOMACH CANCER, BY REGION, 2021 (NUMBER OF PROCEDURES)88
7.3COLON CANCER89
7.3.1COLON CANCER IS THIRD-MOST-COMMON CANCER AND SECOND-LEADING CAUSE OF CANCER DEATHS WORLDWIDE89
TABLE 25ESTIMATED NUMBER OF NEW CASES OF COLON CANCER, BY REGION (2020–2040)89
TABLE 26ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR COLON CANCER, BY COUNTRY, 2020–2027 (USD MILLION)90
TABLE 27ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR COLON CANCER, BY REGION, 2021 (NUMBER OF PROCEDURES)90
7.4ESOPHAGEAL CANCER91
7.4.1GROWING PREVALENCE OF ESOPHAGEAL CANCER ATTRIBUTED TO EXCESS TOBACCO AND ALCOHOL USE91
TABLE 28ESTIMATED NUMBER OF NEW CASES OF ESOPHAGEAL CANCER, BY REGION (2020–2040)91
TABLE 29ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR ESOPHAGEAL CANCER, BY COUNTRY, 2020–2027 (USD MILLION)92
TABLE 30ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR ESOPHAGEAL CANCER, BY REGION, 2021 (NUMBER OF PROCEDURES)92
8ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER93
8.1INTRODUCTION94
TABLE 31ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)94
8.2HOSPITALS94
8.2.1GROWING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES AND ESD PROCEDURES TO SUPPORT GROWTH94
TABLE 32ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)95
8.3SPECIALTY CLINICS95
8.3.1TRANSITION FROM HOSPITAL-BASED PROCEDURES TO CLINIC-BASED PROCEDURES TO BOOST GROWTH95
TABLE 33ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)96
8.4AMBULATORY SURGICAL CENTERS97
8.4.1GROWTH IN ASC SEGMENT DRIVEN BY INCREASING NUMBER OF OUTPATIENT VISITS97
TABLE 34ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)98
8.5OTHER END USERS98
TABLE 35ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)99
9ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION100
9.1INTRODUCTION101
FIGURE 34ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES101
TABLE 36ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION, 2020–2027 (USD MILLION)102
9.2NORTH AMERICA102
FIGURE 35NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SNAPSHOT103
TABLE 37NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)103
TABLE 38NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)104
TABLE 39NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)104
TABLE 40NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)104
9.2.1US105
9.2.1.1US is largest market for endoscopic submucosal dissection products105
TABLE 41US: MACROECONOMIC INDICATORS106
TABLE 42US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)106
TABLE 43US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)106
TABLE 44US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)107
9.2.2CANADA107
9.2.2.1Slower healthcare development in Canada over past decade to restrain growth107
TABLE 45AGE-STANDARDIZED INCIDENCE RATES (ASIR) FOR SELECTED CANCERS IN MEN AND WOMEN IN CANADA, 2020 VS. 2040108
TABLE 46CANADA: MACROECONOMIC INDICATORS109
TABLE 47CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)109
TABLE 48CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)109
TABLE 49CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)110
9.3EUROPE110
TABLE 50EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)110
TABLE 51EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)111
TABLE 52EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)111
TABLE 53EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)111
9.3.1GERMANY112
9.3.1.1Germany to account for largest share of European market112
TABLE 54GERMANY: MACROECONOMIC INDICATORS112
TABLE 55GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)113
TABLE 56GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)113
TABLE 57GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)113
9.3.2FRANCE114
9.3.2.1High-quality healthcare system offering coverage to all citizens to support market growth114
TABLE 58FRANCE: MACROECONOMIC INDICATORS114
TABLE 59FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)115
TABLE 60FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)115
TABLE 61FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)115
9.3.3UK116
9.3.3.1Investments by hospitals to purchase new and advanced endoscopic submucosal dissection equipment to propel market116
TABLE 62UK: MACROECONOMIC INDICATORS116
TABLE 63UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)117
TABLE 64UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)117
TABLE 65UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)117
9.3.4ITALY118
9.3.4.1Receptivity of government toward high-quality and technologically advanced equipment to foster growth118
TABLE 66ITALY: MACROECONOMIC INDICATORS118
TABLE 67ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)119
TABLE 68ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)119
TABLE 69ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)119
9.3.5SPAIN120
9.3.5.1Rising prevalence of cancer to drive market growth120
TABLE 70SPAIN: MACROECONOMIC INDICATORS120
TABLE 71SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)120
TABLE 72SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)121
TABLE 73SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)121
9.3.6REST OF EUROPE121
TABLE 74ROE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)122
TABLE 75ROE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)122
TABLE 76ROE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)123
9.4ASIA PACIFIC123
FIGURE 36ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SNAPSHOT124
TABLE 77ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)125
TABLE 78ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)125
TABLE 79ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)125
TABLE 80ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)126
9.4.1JAPAN126
9.4.1.1Supportive medical device reimbursement policies to drive market growth126
TABLE 81JAPAN: MACROECONOMIC INDICATORS127
TABLE 82JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)127
TABLE 83JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)127
TABLE 84JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)128
9.4.2CHINA128
9.4.2.1Large patient population and strong need for healthcare infrastructure improvements to boost market growth128
TABLE 85CHINA: MACROECONOMIC INDICATORS129
TABLE 86CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)129
TABLE 87CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)129
TABLE 88CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)130
9.4.3INDIA130
9.4.3.1Favorable government initiatives for healthcare infrastructure improvements to support market growth130
TABLE 89INDIA: MACROECONOMIC INDICATORS131
TABLE 90INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)131
TABLE 91INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)131
TABLE 92INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)132
9.4.4REST OF ASIA PACIFIC132
TABLE 93ROAPAC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)133
TABLE 94ROAPAC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)133
TABLE 95ROAPAC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)133
9.5LATIN AMERICA134
9.5.1INCREASING PURCHASING POWER AND HEALTHCARE AFFORDABILITY WILL FAVOR MARKET GROWTH134
TABLE 96LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)135
TABLE 97LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)135
TABLE 98LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)135
9.6MIDDLE EAST AND AFRICA136
9.6.1HEALTHCARE INFRASTRUCTURAL ADVANCEMENTS WILL CREATE NEED FOR HOSPITAL EQUIPMENT AND MEDICAL DEVICES136
TABLE 99MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)136
TABLE 100MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)137
TABLE 101MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)137
10COMPETITIVE LANDSCAPE138
10.1INTRODUCTION138
10.2STRATEGIES ADOPTED BY KEY PLAYERS138
10.3REVENUE ANALYSIS OF KEY MARKET PLAYERS139
FIGURE 37REVENUE ANALYSIS OF KEY PLAYERS OPERATING IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET139
10.4MARKET SHARE ANALYSIS139
FIGURE 38ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SHARE, BY KEY PLAYER (2021)140
10.5COMPANY FOOTPRINT ANALYSIS140
10.5.1FOOTPRINT OF COMPANIES, BY PRODUCT141
10.5.2FOOTPRINT OF COMPANIES, BY END USER142
10.5.3FOOTPRINT OF COMPANIES, BY REGION143
10.6COMPANY EVALUATION MATRIX144
10.6.1STARS144
10.6.2EMERGING LEADERS144
10.6.3PERVASIVE PLAYERS144
10.6.4PARTICIPANTS144
FIGURE 39ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: COMPANY EVALUATION MATRIX145
10.7COMPETITIVE BENCHMARKING146
TABLE 102ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: KEY START-UPS/SMES146
10.8COMPETITIVE SCENARIO146
10.8.1PRODUCT LAUNCHES147
TABLE 103ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: PRODUCT LAUNCHES (JANUARY 2019–DECEMBER 2022)147
10.8.2DEALS148
TABLE 104ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DEALS (JANUARY 2019–DECEMBER 2022)148
10.8.3OTHER DEVELOPMENTS149
TABLE 105ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: OTHER DEVELOPMENTS (JANUARY 2019–DECEMBER 2022)149
11COMPANY PROFILES150
(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)*
11.1KEY PLAYERS150
11.1.1OLYMPUS CORPORATION150
TABLE 106OLYMPUS CORPORATION: BUSINESS OVERVIEW150
FIGURE 40COMPANY SNAPSHOT: OLYMPUS CORPORATION (2022)151
11.1.2FUJIFILM HOLDINGS CORPORATION154
TABLE 107FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW154
FIGURE 41COMPANY SNAPSHOT: FUJIFILM HOLDINGS CORPORATION (2021)155
11.1.3BOSTON SCIENTIFIC CORPORATION158
TABLE 108BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW158
FIGURE 42COMPANY SNAPSHOT: BOSTON SCIENTIFIC CORPORATION (2021)159
11.1.4MEDTRONIC161
TABLE 109MEDTRONIC: BUSINESS OVERVIEW161
FIGURE 43COMPANY SNAPSHOT: MEDTRONIC (2022)162
11.1.5SUMITOMO BAKELITE CO., LTD.164
TABLE 110SUMITOMO BAKELITE CO., LTD.: BUSINESS OVERVIEW164
FIGURE 44COMPANY SNAPSHOT: SUMITOMO BAKELITE CO., LTD. (2021)165
11.1.6CREO MEDICAL GROUP PLC167
TABLE 111CREO MEDICAL GROUP PLC: BUSINESS OVERVIEW167
FIGURE 45COMPANY SNAPSHOT: CREO MEDICAL GROUP PLC (2021)167
11.1.7HOYA CORPORATION170
TABLE 112HOYA CORPORATION: BUSINESS OVERVIEW170
FIGURE 46COMPANY SNAPSHOT: HOYA CORPORATION (2022)171
11.1.8CONMED CORPORATION172
TABLE 113CONMED CORPORATION: BUSINESS OVERVIEW172
FIGURE 47COMPANY SNAPSHOT: CONMED CORPORATION (2021)173
11.1.9STERIS PLC174
TABLE 114STERIS PLC: BUSINESS OVERVIEW174
FIGURE 48COMPANY SNAPSHOT: STERIS PLC (2022)175
11.1.10MTW ENDOSKOPIE MANUFAKTUR177
TABLE 115MTW ENDOSKOPIE MANUFAKTUR: BUSINESS OVERVIEW177
11.2OTHER PLAYERS178
11.2.1OVESCO ENDOSCOPY AG178
TABLE 116OVESCO ENDOSCOPY AG: BUSINESS OVERVIEW178
11.2.2ZEON MEDICAL INC.179
TABLE 117ZEON MEDICAL INC.: BUSINESS OVERVIEW179
11.2.3MICRO-TECH ENDOSCOPY180
TABLE 118MICRO-TECH ENDOSCOPY: BUSINESS OVERVIEW180
11.2.4KARL STORZ SE & CO. KG182
TABLE 119KARL STORZ SE & CO. KG.: BUSINESS OVERVIEW182
11.2.5COOK MEDICAL183
TABLE 120COOK MEDICAL: BUSINESS OVERVIEW183
11.2.6LEO MEDICAL CO., LTD.185
TABLE 121LEO MEDICAL CO., LTD.: BUSINESS OVERVIEW185
11.2.7ERBE ELEKTROMEDIZIN GMBH186
TABLE 122ERBE ELEKTROMEDIZIN GMBH: BUSINESS OVERVIEW186
11.2.8TAEWOONG MEDICAL CO., LTD.187
TABLE 123TAEWOONG MEDICAL CO., LTD.: BUSINESS OVERVIEW187
11.2.9DCC HEALTHCARE LIMITED188
TABLE 124DCC HEALTHCARE LIMITED: BUSINESS OVERVIEW188
11.2.10KOSSEN CO., LTD.189
TABLE 125KOSSEN CO., LTD.: BUSINESS OVERVIEW189
11.2.11INNOVAMEDICA S.P.A.190
TABLE 126INNOVAMEDICA S.P.A.: BUSINESS OVERVIEW190
11.2.12JIANGSU VEDKANG MEDICAL SCIENCE AND TECHNOLOGY CO., LTD.191
TABLE 127JIANGSU VEDKANG MEDICAL SCIENCE AND TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW191
11.2.13HANGZHOU AGS MEDICAL TECHNOLOGICAL CO., LTD.192
TABLE 128HANGZHOU AGS MEDICAL TECHNOLOGICAL CO., LTD.: BUSINESS OVERVIEW192
11.2.14BEIJING ZKSK TECHNOLOGY CO., LTD.193
TABLE 129BEIJING ZKSK TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW193
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies.
12APPENDIX194
12.1DISCUSSION GUIDE194
12.2KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL199
12.3CUSTOMIZATION OPTIONS201
12.4RELATED REPORTS201
12.5AUTHOR DETAILS202
Related Report
